Form 4: Bio-Key International CFO Cecilia Welch Reports Acquisition of 22,500 Shares of Common Stock

Cecilia Welch, CFO of Bio-Key International, reports the acquisition of 22,500 shares of common stock granted under the company's 2023 Stock Incentive Plan.

Summary

• Cecilia Welch, the Chief Financial Officer of Bio-Key International, filed a Form 4 on August 2, 2024.
• The report details a transaction on July 31, 2024, where Ms. Welch acquired 22,500 shares of Bio-Key International common stock.
• These shares were granted under the Issuer's 2023 Stock Incentive Plan.
• The restricted stock vests in three equal annual installments on each of the next three anniversaries of the grant date, contingent upon Ms. Welch's continued employment with the company.
• Following the reported transaction, Ms. Welch beneficially owns 24,396 shares of common stock, excluding options to purchase 348 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions by an insider. The acquisition of shares by the CFO could be seen as a slightly positive sign, but it's primarily a routine disclosure.

Positives

• The acquisition of shares by the CFO could be interpreted as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The restricted stock vests over the next three years, contingent on continued employment.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the CFO's holdings of the company's stock.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it reflects the CFO's increased stake in the company.

Key Dates

Keywords

Form 4, BIO-KEY INTERNATIONAL, BKYI, Cecilia Welch, CFO, Stock Incentive Plan, Common Stock, Beneficial Ownership